DiscoverSUFU podcastSUFU 23 Panel: Beta-3 Agonists in the Treatment of Overactive Bladder
SUFU 23 Panel: Beta-3 Agonists in the Treatment of Overactive Bladder

SUFU 23 Panel: Beta-3 Agonists in the Treatment of Overactive Bladder

Update: 2023-12-20
Share

Description

Moderator:  J. Quentin Clemens, MD, FACS
Risk Profile of Anticholinergic Agents vs Beta-3 Agonists
Panelist: Anne M. Suskind, MD, MS, FACS, FPMRS
 Efficacy of Anticholinergic Agents vs Beta-3 Agonists
Panelist: Blayne Welk, MD
 What About Neurogenic Bladder?
Panelist: Christopher S. Elliott, MD, PhD

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

SUFU 23 Panel: Beta-3 Agonists in the Treatment of Overactive Bladder

SUFU 23 Panel: Beta-3 Agonists in the Treatment of Overactive Bladder